25 June 2024
25 June 2024
At the Outsourcing in Clinical Trials UK and Ireland Conference, prominent figures in UK healthcare highlighted areas for change.
Research indicates that designing clinical trials with the patient in mind reduces recruitment times and enhances trial performance. Daniel J. Herron, a life sciences specialist, explains why one of the key factors in improving participant involvement is document readability.
The KRAS inhibitor is expected to generate $1.3bn in global sales in 2029, as per GlobalData’s analysis.
As the obesity drug development space gains traction, Altimmune shared positive data from a Phase II trial for pemvidutide.
The second fill and finishing unit in the region will expand the manufacturing capacity in the US for injectable treatments.
The MHLW granted the approval on results from the MOMENTUM and SIMPLIFY-I Phase III trials.
Alimera Sciences shares have increased in value following a $5.50 per share buyout offer from ANI Pharmaceuticals.
The company will offer the vaccine in unit-dose vials for distribution within the European Union on receipt of approval.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
